MedTrace Logo

MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

NCT06208397 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-05-15

No results posted yet for this study

Summary

The goal of this study is to investigate the value of MR elastography-based SII as a means of detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct measure of tumor-liver adhesion to investigate the relationship between imaging findings and pathophysiological changes in the Liver.

Conditions

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance Elastography and routine MRI

Assessed boundary conditions through MRE-base SII before surgery and recorded HGP of tumor after surgery.

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Principal Investigators

  • Yu Shi, M.D. · Shengjing Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-24
Primary Completion
2025-12-24
Completion
2026-12-24

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06208397 on ClinicalTrials.gov